Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 198,572 shares at $1.81 ($352K) on 2017-12-26, disclosed to the SEC on 2017-12-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.61 | 17,982 | $29K | 8.2% |
| 2 | $1.81 | 51,442 | $93K | 26.4% |
| 3 | $1.81 | 51,442 | $93K | 26.4% |
| 4 | $1.76 | 50,000 | $88K | 25.0% |
| 5 | $1.77 | 27,706 | $49K | 13.9% |
| Total | $1.77 avg | 198,572 |
| $352K |
| 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-08 | $42K | — | Filing → |